These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 220823

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Responsiveness of the glucocorticoid-suppressed pituitary-adrenocortical system of pigeons (Columba livia domestica) to stimulation with arginine vasopressin.
    Westerhof I, Van den Brom WE, Mol JA.
    Avian Dis; 1996; 40(2):312-20. PubMed ID: 8790880
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Suppression of cortisol responses to exogenous adrenocorticotrophic hormone, and the occurrence of side effects attributable to glucocorticoid excess, in cats during therapy with megestrol acetate and prednisolone.
    Middleton DJ, Watson AD, Howe CJ, Caterson ID.
    Can J Vet Res; 1987 Jan; 51(1):60-5. PubMed ID: 3032391
    [Abstract] [Full Text] [Related]

  • 25. [Indices of the state of the pituitary-adrenal system in hereditary myopathies].
    Temin PA, Gerasimova OI, Savost'ianova NA, Medvedev MI, Faustov VS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Jan; 81(3):342-6. PubMed ID: 6266180
    [No Abstract] [Full Text] [Related]

  • 26. Hypothalamic-pituitary-adrenal axis following glucocorticoid prophylaxis against acute mountain sickness.
    Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W.
    Horm Metab Res; 2002 Jun; 34(6):318-24. PubMed ID: 12173072
    [Abstract] [Full Text] [Related]

  • 27. Results of treatment of certain diseases of the central nervous system with ACTH and corticosteroids.
    Baumann J.
    Acta Neurol Scand Suppl; 1965 Jun; 13 Pt 2():453-61. PubMed ID: 4284452
    [No Abstract] [Full Text] [Related]

  • 28. Immunosuppressive therapy in neurological diseases.
    Cendrowski W, Riekkinen PJ, Rinne UK.
    Ann Clin Res; 1974 Dec; 6(6):323-9. PubMed ID: 4375431
    [No Abstract] [Full Text] [Related]

  • 29. [Myasthenia gravis and steroid therapy].
    Wakata N, Nemoto H, Niizuma M, Araki Y, Kinoshita M.
    Rinsho Shinkeigaku; 1992 Feb; 32(2):131-7. PubMed ID: 1611770
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Corticosteroids in neurology].
    Staal A.
    Ned Tijdschr Geneeskd; 1976 May 01; 120(18):786-92. PubMed ID: 772454
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immunointervention with cyclosporin A in autoimmune neurological disorders.
    Tindall RS.
    J Autoimmun; 1992 Apr 01; 5 Suppl A():301-13. PubMed ID: 1503626
    [Abstract] [Full Text] [Related]

  • 34. [Use of vitamins B-1 and B-12 combined with UTP in the treatment of various diseases of the nervous and muscular systems].
    Mussini C, Neviani V.
    Clin Ter; 1969 Jan 15; 48(1):53-73. PubMed ID: 5386425
    [No Abstract] [Full Text] [Related]

  • 35. [Current therapeutic possibilities in neurology].
    Uldry PA.
    Rev Med Suisse Romande; 1992 Jul 15; 112(7):629-34. PubMed ID: 1496214
    [No Abstract] [Full Text] [Related]

  • 36. [Therapy of nervous system diseases with ACTH and experimental studies on its mechanism of action, with special reference to the nonadrenal effects of ACTH].
    Hiraki K, Kitajima K, Makihata T, Takahara J, Osato N.
    Nihon Rinsho; 1966 Jun 15; 24(6):1206-14. PubMed ID: 4290418
    [No Abstract] [Full Text] [Related]

  • 37. Recurrent myelitis in localized scleroderma.
    Miyamoto M, Kinoshita M, Tanaka K, Tanaka M.
    Clin Neurol Neurosurg; 2014 Dec 15; 127():140-2. PubMed ID: 25459261
    [No Abstract] [Full Text] [Related]

  • 38. [Administration of steroids with least adverse effects].
    Ofuji M.
    Horumon To Rinsho; 1976 Sep 15; 24(9):889-95. PubMed ID: 188575
    [No Abstract] [Full Text] [Related]

  • 39. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.
    Lee DA, Taylor GM, James VH, Walker G.
    Gut; 1979 May 15; 20(5):349-55. PubMed ID: 223947
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.